The drug is expected to offer nerve regeneration, potentially modifying the disease in diabetic peripheral neuropathy ...

Brakes For Breasts is different from any other breast cancer campaign: The Dr. Tuohy Lab is a team of researchers at the Cleveland Clinic has actually created a vaccine that has proved effective in ...

Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market ...

Immatics announced updated Phase 1b data for its IMA203 therapy in metastatic melanoma. A deep tumor reduction response was observed in about half of the patients, with positive survival benefits ...

A phase 1b trial showed promising results among patients with relapsed or refractory chronic lymphocytic leukemia.

Tempest Therapeutics enters a Phase 3 trial for its liver cancer drug amezalpat, in collaboration with Roche. The trial ...

Boeing subsidiary Aurora Flight Sciences is working on a high-speed VTOL military aircraft as part of DARPA's Speed & Runway ...

Immatics has vaulted into phase 3 on the strength of early-stage data. The biotech is gearing up to start a pivotal trial of ...

In the Phase 1b dose expansion part of the study, heavily pretreated patients with metastatic melanoma were treated with IMA203. Data from the study showed a significant positive shift in median ...

Company announces updated Phase 1b clinical data on ACTengine® IMA203 targeting PRAME in 28 heavily pretreated metastatic melanoma patients with substantially enhanced maturity compared to the last ...

NewMed Energy secured new borrowings of up to $400 million from Israeli banks to be used for ongoing operations including an ...